Harvard Bioscience (HBIO) Other Non-Current Assets (2016 - 2025)
Harvard Bioscience (HBIO) has disclosed Other Non-Current Assets for 16 consecutive years, with $2.7 million as the latest value for Q4 2025.
- Quarterly Other Non-Current Assets fell 5.08% to $2.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.7 million through Dec 2025, down 5.08% year-over-year, with the annual reading at $2.7 million for FY2025, 5.08% down from the prior year.
- Other Non-Current Assets for Q4 2025 was $2.7 million at Harvard Bioscience, down from $3.8 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $8.7 million in Q2 2022, with the low at $724000.0 in Q3 2021.
- Average Other Non-Current Assets over 5 years is $4.7 million, with a median of $4.3 million recorded in 2024.
- The sharpest move saw Other Non-Current Assets soared 1047.24% in 2022, then plummeted 69.39% in 2024.
- Over 5 years, Other Non-Current Assets stood at $5.4 million in 2021, then surged by 44.74% to $7.8 million in 2022, then decreased by 16.8% to $6.5 million in 2023, then crashed by 56.23% to $2.8 million in 2024, then fell by 5.08% to $2.7 million in 2025.
- According to Business Quant data, Other Non-Current Assets over the past three periods came in at $2.7 million, $3.8 million, and $3.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.